Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation–Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma
Titel:
Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation–Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma
Auteur:
Puronen, Camille E. Cassaday, Ryan D. Stevenson, Philip A. Sandmaier, Brenda M. Flowers, Mary E. Green, Damian J. Maloney, David G. Storb, Rainer F. Press, Oliver W. Gopal, Ajay K.